| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.10. | Park Dental Partners, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 23.09. | Park Dental adds Sapphire Dental Care to Arizona network | 1 | Investing.com | ||
| PARK DENTAL PARTNERS Aktie jetzt für 0€ handeln | |||||
| 23.09. | Park Dental Partners Expands Arizona Presence with Addition of Sapphire Dental Care | 2 | GlobeNewswire (USA) | ||
| 14.08. | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | 1.449 | AFX News | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| 13.08. | Park Dental Partners, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 13.08. | Earnings Call: Park Dental Partners übertrifft EPS-Schätzungen für Q2 2026 deutlich | 2 | Investing.com Deutsch | ||
| 13.08. | Transcript: Park Dental Partners Q2 2026 Earnings Conference Call | 1 | Benzinga.com | ||
| 12.08. | Park Dental Partners Announces Second Quarter 2026 Results | 204 | GlobeNewswire (Europe) | MINNEAPOLIS, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices ("Park Dental Partners," "we," "our," "us," or the "Company") today reported... ► Artikel lesen | |
| 10.08. | Park Dental Partners, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 04.06. | Park Dental Partners Expands Presence in Rochester, Minn., with Addition of Zumbro View Dental | 2 | GlobeNewswire (USA) | ||
| 02.06. | Park Dental Partners, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 14.05. | Park Dental Partners, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 14.05. | Transcript: Park Dental Partners Q1 2026 Earnings Conference Call | 2 | Benzinga.com | ||
| 13.05. | Park Dental Partners, Inc. Non-GAAP EPS of $0.44 beats by $0.24, revenue of $62.7M beats by $1.7M | 2 | Seeking Alpha | ||
| 13.05. | Park Dental Partners, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.05. | Park Dental Partners Announces First Quarter 2026 Results | 258 | GlobeNewswire (Europe) | MINNEAPOLIS, May 13, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices ("Park Dental Partners," "we," "our," "us," or the "Company") today reported... ► Artikel lesen | |
| 10.12.25 | XFRA NEW INSTRUMENTS AVAILABLE ON 10.12.2025 | 2.172 | Xetra Newsboard | The following instruments on XETRA do have their first trading 10.12.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.12.2025
Aktien
1 JP3108030002 Axyz Co. Ltd.
2 JP3431200009... ► Artikel lesen | |
| 04.12.25 | Park Dental Partners, Inc. Announces Closing of Initial Public Offering | 357 | Business Wire | MINNEAPOLIS & ST. PAUL, Minn.--(BUSINESS WIRE)--Park Dental Partners, Inc. ("Park Dental Partners" or the "Company"), today announced the closing of its initial public offering of 1,535,000 shares of... ► Artikel lesen | |
| 02.12.25 | Park Dental Partners, Inc. Announces Pricing of Initial Public Offering | 375 | Business Wire | MINNEAPOLIS & ST. PAUL, Minn.--(BUSINESS WIRE)--Park Dental Partners, Inc. ("Park Dental Partners" or the "Company") today announced the pricing of its initial public offering of 1,535,000 shares of... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDLINE | 28,800 | -0,69 % | EQS-News: Medline Europe: Medline und WRAP feiern 10 Jahre Zusammenarbeit für verantwortungsvolle und nachhaltige Produktion | EQS-News: Medline Europe
/ Schlagwort(e): ESG/ESG
Medline und WRAP feiern 10 Jahre Zusammenarbeit für verantwortungsvolle und nachhaltige Produktion
26.10.2026 / 10:05... ► Artikel lesen | |
| OMADA HEALTH | 17,400 | +3,57 % | Citizens reiterates Omada Health stock rating ahead of Q3 results | ||
| ADVANCED BIOMED | 2,350 | +2,17 % | Morning Market Movers: InMed Pharmaceuticals, INLIF Limited, China SXT Pharmaceuticals, Advanced Biomed See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| MINIMED GROUP | 16,050 | -5,31 % | Medtronic plc: Medtronic Completes Separation of MiniMed Group, Inc. | GALWAY, Ireland, Oct. 15, 2026 /PRNewswire/ -- Medtronic plc (Medtronic; NYSE: MDT) today announced the completion of its separation of MiniMed Group, Inc. (MiniMed... ► Artikel lesen | |
| CUPRINA HOLDINGS | 1,750 | -1,13 % | Cuprina Holdings (Cayman) LTD: Cuprina (Nasdaq: CUPR) to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare Group | Acquiring 100% of East Coast Podiatry (five clinics) and Orchard Clinic (two clinics) for approximately S$4.0 million (approximately US$3.1 million)Target Group generated FY2025 unaudited revenue... ► Artikel lesen | |
| CARLSMED | 14,100 | +1,44 % | Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026 | ||
| SHOULDER INNOVATIONS | 18,000 | 0,00 % | Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch | Second Product Introduction on New Line of Technologies for Metal-Sensitive Patients
GRAND RAPIDS, Mich., Sept. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc.... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,890 | 0,00 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,400 | -2,58 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 66,97 | +0,12 % | Earnings Call: BrightSpring Health Services übertrifft Prognosen für Q3 2026 deutlich - Starkes Umsatz- und EBITDA-Wachstum | ||
| FRESENIUS | 47,795 | +1,69 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Fresenius mit einem Kursziel von 55,20 Euro auf "Overweight" belassen. Für die Quartalszahlen des Medizinkonzerns am 4. November liege er beim... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 7,280 | +0,14 % | Alignment Healthcare lowers 2026 outlook as it navigates cost headwinds | ||
| HEARTFLOW | 59,11 | +0,10 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| GERRESHEIMER | 32,040 | +0,44 % | JPMORGAN stuft GERRESHEIMER AG auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Gerresheimer mit einem Kursziel von 46 Euro auf "Overweight" belassen. David Adlington passte sein Bewertungsmodell für den Verpackungsspezialisten... ► Artikel lesen | |
| GENEDX | 69,04 | -0,03 % | GeneDx plans to add long-read genome sequencing to portfolio |